Abstract Details
|
PRESENTER |
No disclosure on file |
| Julie Van Der Zee | No disclosure on file |
| No disclosure on file | |
| Sebastiaan Engelborghs, MD, PhD (University of Antwerp, Biomedical Sciences) | No disclosure on file |
| Anne Sieben, MD (Gent University Hospital) | Dr. Sieben has nothing to disclose. |
| Tim Van Langenhove, MD, PhD (UZ Gent) | Dr. Van Langenhove has nothing to disclose. |
| Jan L. De Bleecker, MD, PhD, FAAN (Neurology/University Hospital) | Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ArgNX. Dr. De Bleecker has received personal compensation in the range of $0-$499 for serving as a Consultant for Biogen. Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson and Johnson. Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. The institution of Dr. De Bleecker has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for CSL Behring. Dr. De Bleecker has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. De Bleecker has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. De Bleecker has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL Behring. Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. De Bleecker has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. De Bleecker has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen pharmaceuticals. |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| Patrick Cras, MD, PhD (University of Antwerp) | The institution of Dr. Cras has received research support from Belgian Fund for Scientific Research. Dr. Cras has received personal compensation in the range of $0-$499 for serving as a member with National Bioethics Committee. |
| Rik R. Vandenberghe | No disclosure on file |
| No disclosure on file | |
| Jean-Jacques Martin, MD (Universiteit Antwerpen (formerly)) | No disclosure on file |
| Peter P. De Deyn, MD, PhD | Dr. De Deyn has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for elsevier. |
| No disclosure on file | |
| Christine Van Broeckhoven, PhD (University of Antwerp - CDE) | Dr. Van Broeckhoven has nothing to disclose. |